{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:45:13Z","timestamp":1778651113427,"version":"3.51.4"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 79-year-old man with locally metastatic papillary thyroid cancer to left-sided cervical lymph nodes was referred for radioiodine therapy. He was considered unfit for thyroidectomy due to extensive local involvement and severe interstitial lung disease requiring continuous oxygen. The patient was treated with low doses of radioiodine (approximately 30 mCi) every 6 months with corticosteroid cover for 3 years with good effect. Sequential <jats:sup>131<\/jats:sup>I scanning and serum thyroglobulin levels confirmed virtual complete ablation of the thyroid gland. The patient remained well on thyroid hormone replacement.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003686","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T15:07:26Z","timestamp":1621868846000},"page":"915-918","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["131I Ablation of an Entire Thyroid Gland in Locally Invasive Differentiated Thyroid Cancer Without Surgery"],"prefix":"10.1097","volume":"46","author":[{"given":"Grace","family":"Yung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Forwood","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Concord Hospital, Concord"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirtan","family":"Ganda","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Concord Hospital, Concord, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Mansberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","year":"2016","journal-title":"Thyroid"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00259-019-04479-1","article-title":"Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade","volume":"47","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"suppl 1","key":"bib3-20250621","first-page":"i1","article-title":"A non-surgical approach to the treatment of metastatic follicular thyroid cancer (FTC) in a medically high-risk patient","volume":"33","year":"2012","journal-title":"Endocr Rev"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00006231-200302000-00013","article-title":"Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer","volume":"24","year":"2003","journal-title":"Nucl Med Commun"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1210\/jcem-50-4-734","article-title":"Influence of triiodothyronine withdrawal time on 131I uptake postthyroidectomy for thyroid cancer","volume":"50","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00000421-199802000-00018","article-title":"Use of radioactive iodine for thyroid remnant ablation in well-differentiated thyroid carcinoma to replace thyroid reoperation","volume":"21","year":"1998","journal-title":"Am J Clin Oncol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00006231-200403000-00006","article-title":"Differentiated thyroid cancer: radioiodine following lobectomy\u2014a clinical feasibility study","volume":"25","year":"2004","journal-title":"Nucl Med Commun"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1056\/NEJMoa1109589","article-title":"Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer","volume":"366","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:00:20Z","timestamp":1750536020000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":8,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003686","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,20]]}}}